Flamel Technologies SA (NASDAQ:FLML)
| 4.68 Data as of 3:08pm ET |  +0.0243 / +0.52%Today’s Change | 2.85 Today|||52-Week Range 5.62 | +54.60% Year-to-Date |
Latest FLML News | Press Releases
No recent news for Flamel Technologies SA.
Today’s Trading
| Previous close | 4.66 |
| Today’s open | 4.61 |
| Day’s range | 4.61 - 4.72 |
| Volume | 8,775 |
| Average volume (3 months) | 47,164 |
| Market cap | $118.4M |
| Dividend yield | -- |
Data as of 3:08pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | +63.71% |
| Earnings growth (this year) | -25.32% |
| Earnings growth (next 5 years) | +25.00% |
| Revenue growth (last year) | -19.52% |
| P/E ratio | NM |
| Price/Sales | 2.89 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CHTPChelsea Therapeutics... | +0.02 | +1.36% |
| NWBONorthwest Biotherape... | -0.04 | -1.08% |
| ACURAcura Pharmaceutical... | -0.10 | -4.17% |
| ATHXAthersys Inc | -0.06 | -3.11% |
Data as of 3:30pm ET, 05/21/2013
Financials
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | -$0.27 |
| Annual revenue (last year) | $26.3M |
| Annual profit (last year) | -$3.3M |
| Net profit margin | -12.37% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman & Investor Relations Contact Stephen H. Willard |
Chief Executive Officer & Director Michael Shannon Anderson |
Corporate headquarters Vénissieux, Rhone-alpes |
Forecasts
